Subdural Levels of Interleukin 1-receptor Antagonist are Elevated in Patients with Recurrent Chronic Subdural Hematomas

[1]  F. Poulsen,et al.  The Danish chronic subdural hematoma study - risk factors for second recurrence. , 2022, World neurosurgery.

[2]  Yu Deng,et al.  Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma , 2022, Frontiers in Neurology.

[3]  S. Mariotto,et al.  Treatment Options in Refractory Autoimmune Encephalitis , 2022, CNS Drugs.

[4]  M. Charlson,et al.  Charlson Comorbidity Index: A Critical Review of Clinimetric Properties , 2022, Psychotherapy and Psychosomatics.

[5]  K. Chu,et al.  Anakinra treatment for refractory cerebral autoinflammatory responses , 2021, Annals of clinical and translational neurology.

[6]  U. Ziemann,et al.  Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever , 2021, Wiener Medizinische Wochenschrift.

[7]  A. Unterberg,et al.  Relevance of comorbidities and antithrombotic medication as risk factors for reoperation in patients with chronic subdural hematoma , 2021, Neurosurgical Review.

[8]  F. Poulsen,et al.  The Danish Chronic Subdural Hematoma Study—comparison of hematoma age to the radiological appearance at time of diagnosis , 2020, Acta Neurochirurgica.

[9]  P. Hutchinson,et al.  Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy , 2017, Journal of Neuroinflammation.

[10]  M. Stanišić,et al.  A Reliable Grading System for Prediction of Chronic Subdural Hematoma Recurrence Requiring Reoperation After Initial Burr-Hole Surgery , 2017, Neurosurgery.

[11]  Hongyan Yuan,et al.  Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma. , 2015, Journal of neurotrauma.

[12]  M. Stanišić,et al.  The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Subdural Hematoma Patients Assessed with Factor Analysis , 2014, PloS one.

[13]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[14]  H. Yokota,et al.  Measurement of inflammatory cytokines and thrombomodulin in chronic subdural hematoma. , 2012, Neurologia medico-chirurgica.

[15]  Jos W. M. van der Meer,et al.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.

[16]  A. Tsung,et al.  Recurrence-free chronic subdural hematomas: a retrospective analysis of the instillation of tissue plasminogen activator in addition to twist drill or burr hole drainage in the treatment of chronic subdural hematomas. , 2012, World neurosurgery.

[17]  Ha-young Choi,et al.  Independent predictors for recurrence of chronic subdural hematoma , 2012, Acta Neurochirurgica.

[18]  M. Stanišić,et al.  Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study , 2012, Inflammation Research.

[19]  H. Boysson,et al.  Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence , 2012, Clinical Rheumatology.

[20]  A. Helmy,et al.  Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury , 2011, Progress in Neurobiology.

[21]  M. Stanišić,et al.  Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study , 2011, Acta Neurochirurgica.

[22]  M. Bisceglia,et al.  Successful Treatment of Schnitzler's Syndrome with Anakinra after Failure of Rituximab Trial , 2010, International journal of immunopathology and pharmacology.

[23]  G. Nishimura,et al.  Effect of anakinra on arthropathy in CINCA/NOMID syndrome , 2010, Pediatric rheumatology online journal.

[24]  Dirk E. Smith,et al.  The IL-1 family: regulators of immunity , 2010, Nature Reviews Immunology.

[25]  S. Ozen,et al.  Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease , 2010, Clinical Rheumatology.

[26]  M. Mase,et al.  Involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in the mechanism of development of chronic subdural hematoma. , 2009, Neurologia medico-chirurgica.

[27]  N. Marklund,et al.  Neutralization of interleukin‐1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice , 2009, The European journal of neuroscience.

[28]  A. Vaag,et al.  Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes , 2009, Diabetes Care.

[29]  Jae-Min Kim,et al.  Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. , 2009, Surgical neurology.

[30]  J. Pickard,et al.  Inflammation in Human Brain Injury: Intracerebral Concentrations of IL-1α, IL-1β, and Their Endogenous Inhibitor IL-1ra , 2007 .

[31]  Shin Jung,et al.  Possible Pathophysiological Role of Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinases (MMPs) in Metastatic Brain Tumor-associated Intracerebral Hemorrhage , 2006, Journal of Neuro-Oncology.

[32]  I. McInnes,et al.  Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. , 2004, Current opinion in pharmacology.

[33]  R. Delfini,et al.  Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. , 2004, Journal of neurosurgery.

[34]  T. Wynn.  IL-13 effector functions. , 2003, Annual review of immunology.

[35]  S. Abramson,et al.  Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. , 2002, Rheumatology.

[36]  Satoshi O. Suzuki,et al.  Vascular endothelial growth factor in chronic subdural haematomas , 2001, Journal of Clinical Neuroscience.

[37]  T. Kubota,et al.  Expression of Matrix Metalloproteinases in the Chronic Subdural Haematoma Membrane , 2000, Acta Neurochirurgica.

[38]  D G Altman,et al.  Statistics notes: Absence of evidence is not evidence of absence , 1995 .

[39]  J. Tavernier,et al.  Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion , 1994, The Journal of experimental medicine.

[40]  S. Akira,et al.  Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.

[41]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.